5-Ene-2-arylaminothiazol-4(5H)-ones Induce Apoptosis in Breast Cancer Cells
Cells · 2025
DOI: 10.3390/cells14120861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Rostyslav Dudchak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Synthesis and Technology of Drugs, Faculty of Pharmacy, Medical University of Bialystok, Jana Kilińskiego 1, 15-089 Bialystok, Poland. Hauptthemen laut MEDLINE: Apoptosis, Breast Neoplasms, Antineoplastic Agents, Thiazoles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Białystok, National Research Foundation of Ukraine, Medical University of Bialystok.
Abstract (Originalsprache)
As breast cancer remains a significant challenge for the current medical field, molecules with a 4-thiazolidinone scaffold can become promising candidates for addressing the increasing threat of cancer. This study aims to develop and evaluate the novel 4-thiazolidinone derivatives with anticancer potential. New compounds were synthesized through two different pathways, one as a two-step process and the other as a one-pot method. The second approach fits the requirements of cost-effective methodologies and allows for the reduction of synthetic steps, reagents, and reaction time. The obtained data from in vitro research showed a potent cytotoxic activity of the novel structures in micromolar concentrations against MCF-7 breast cancer cells. Further investigations into their anticancer activity revealed that the tested compounds induced apoptosis through intrinsic and extrinsic pathways, which was evidenced by their capability to reduce the mitochondrial membrane potential and induce the activation of caspases 7, 8, 9, and 10. A more detailed analysis uncovered that one of the novel compounds can affect the expression of key apoptotic proteins, tumor protein P53 (p53), cytochrome C, and Bax in treated cells. Additionally, these compounds displayed an enhanced generation of reactive oxygen species (ROS) in MCF-7 cells, which suggests that ROS-mediated mechanisms can take part in the anticancer potential of the synthesized compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Synthesis and Technology of Drugs, Faculty of Pharmacy, Medical University of Bialystok, Jana Kilińskiego 1, 15-089 Bialystok, Poland.
- Department of Biotechnology, Faculty of Pharmacy, Medical University of Bialystok, Jana Kilińskiego 1, 15-089 Bialystok, Poland.
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Pekarska 69, 79010 Lviv, Ukraine.
- Department of Chemistry, Taras Shevchenko National University of Kyiv, 64 Volodymyrska St., 01033 Kyiv, Ukraine.
- Enamine Ltd., Winston Churchill 78, 02094 Kyiv, Ukraine.
- Molecular Design Center, Danylo Halytsky Lviv National Medical University, Pekarska 69, 79010 Lviv, Ukraine.
ORCID-Profile: Robert Czarnomysy, Agnieszka Gornowicz, Olexandr Karpenko, Serhii Holota, Krzysztof Bielawski, Roman Lesyk
Förderung
- Medical University of Białystok
- National Research Foundation of Ukraine
- Medical University of Bialystok
Zitieren
APA
Dudchak, R., Podolak, M., Sydorenko, I., Czarnomysy, R., Gornowicz, A., Karpenko, O., Holota, S., Bielawska, A., Bielawski, K., & Lesyk, R. (2025). 5-Ene-2-arylaminothiazol-4(5H)-ones Induce Apoptosis in Breast Cancer Cells. Cells. https://doi.org/10.3390/cells14120861
Vancouver
Dudchak R, Podolak M, Sydorenko I, Czarnomysy R, Gornowicz A, Karpenko O, et al. 5-Ene-2-arylaminothiazol-4(5H)-ones Induce Apoptosis in Breast Cancer Cells. Cells. 2025. doi:10.3390/cells14120861
BibTeX
@article{Dudchak2025,
author = {Dudchak, Rostyslav and Podolak, Magdalena and Sydorenko, Ivan and Czarnomysy, Robert and Gornowicz, Agnieszka and Karpenko, Olexandr and Holota, Serhii and Bielawska, Anna and Bielawski, Krzysztof and Lesyk, Roman},
title = {5-Ene-2-arylaminothiazol-4(5H)-ones Induce Apoptosis in Breast Cancer Cells},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14120861}
}
EUVIMED